Identification |
Name: | Pyrimidine,2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-, hydrochloride (1:1) |
Synonyms: | Pyrimidine,2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-, monohydrochloride (9CI);Piribedil hydrochloride;2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine hydrochloride;Pyrimidine, 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-, hydrochloride (1:1);2-(4-Piperonyl-1-piperazinyl)pyrimidine hydrochloride;Piribedil hydrochloride;Pyrimidine, 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)-, monohydrochloride; |
CAS: | 78213-63-5 |
Molecular Formula: | C16H19ClN4O2 |
Molecular Weight: | 334.8 |
InChI: | InChI=1/C16H18N4O2.ClH/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14;/h1-5,10H,6-9,11-12H2;1H |
Molecular Structure: |
|
Properties |
Flash Point: | 237.7°C |
Boiling Point: | 469.4°C at 760 mmHg |
Biological Activity: | A direct dopamine agonist, in clinical use for treatment of dopaminergic system dysfunction. Recent work suggests that it is selective for the D 3 subtype, for which it has 20 times higher affinity than for D 2 , and possesses no significant affinity for D 1 ? receptors. |
Flash Point: | 237.7°C |
Storage Temperature: | Store at RT |
Safety Data |
|
|